Clinical outcome, Pathological results and immunohistochemical findings of rare subtypes of soft tissue sarcomas KU Leuven
Soft tissue sarcoma (STS) represent a highly heterogeneous group of rare, malignant tumors of mesenchymal origin, with more than 50 subtypes described. For the majority of advanced, metastatic cases of STS, clinicians still have to rely on conventional chemotherapy. Despite all efforts, advanced-stage STS is still almost invariably fatal, showing a clear need for novel therapies and the identification of patients who might benefit from these ...